Drug maker Merck  Co said it would stop using chimpanzees in its biomedical research joining several other companies and government agencies that have phased out use of the primates in testing drugs and vaccines Merck of Whitehouse Station NJ cited the availability of alternative methodologies that in many cases can replace the need for chimpanzees whose close relationship to humans has raised ethical issues over their use in drug research The company made the decision in late  and disclosed it in an update
  